-
Sector Analysis
Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyperphosphatemia (HP), and Hyperkalemia (HK) – Global Drug Forecast and Market Analysis to 2030
CKD is a chronic condition in which patients suffer from an irreversible and progressive loss in renal function over many months or years, ultimately resulting in end-stage renal disease and the requirement for renal replacement therapy. CKD manifests when both kidneys are damaged sufficiently to hinder the removal of metabolic products from the body and the ability to provide mineral balance. The Centers for Disease Control and Prevention states that approximately 96% of people with kidney damage or mild to...
-
Sector Analysis
Gastric and Gastroesophageal Junction Adenocarcinoma – Global Drug Forecast and Market Analysis to 2029
Gastric and gastroesophageal junction adenocarcinoma (G/GEJAC) is the fifth most common form of cancer and the fourth leading cause of cancer-related death worldwide, yet little is known about its exact etiology despite much ongoing research. Notably, G/GEJAC incidence rates are much higher in East Asia, particularly in Japan, China, and Korea. Approximately 90–95% of G/GEJACs are adenocarcinomas, while the rest represent rarer gastric malignancies, such as gastrointestinal stromal tumors, lymphomas, and neuroendocrine tumors. Historically, treatment of G/GEJAC has been mostly...
-
Sector Analysis
Wealth in Germany: Sizing the Market Opportunity 2018
"Wealth in Germany: Sizing the Market Opportunity 2018", analyzes Germany’s wealth and retail savings and investments markets, with a focus on the HNW segment. The report is based on our proprietary datasets. The upswing in the German economy and strong stock market performance have presented significant opportunities for German wealth managers, not only to grow assets under management but also to gain new clients. However, with changes to capital gains tax on the horizon and falling real returns in the...
-
Sector Analysis
Australian Mortgage Market: Forecasts and Future Opportunities 2018
"Australian Mortgage Market: Forecasts and Future Opportunities 2018", report looks at the Australian residential mortgage market, with coverage of both the investment property and owner-occupier market, including first-time buyers. The Australian mortgage market has gone from strength to strength in recent years, but growth is finally tipped to decelerate as investors take a breath and property inflation cools in the country’s key cities. An active regulator has sapped much of the bubble in the investment property market, which will result...
-
Sector Analysis
Biopower in Taiwan, Market Outlook to 2030, Update 2017 – Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Biopower in Taiwan, Market Outlook to 2030, Update 2017 – Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the Biopower market in Taiwan. The report provides an in-depth analysis on global renewable power market and global Biopower market with forecasts up to 2030. The report analyzes the power market scenario in Taiwan (includes conventional Hydro, nuclear and renewable...
-
Sector Analysis
Chronic Lymphocytic Leukemia: Opportunity Analysis and Forecasts to 2027
Chronic lymphocytic leukemia (CLL) is a form of cancer that originates from lymphocytes in the bone marrow and later invades the blood and/or lymphoid tissues. CLL treatment has been transformed since the novel oral targeted agents Imbruvica (ibrutinib), Zydelig (idelalisib), and Venclexta (venetoclax) were introduced to the market from 2014 onwards and challenged the prior dominance of chemoimmunotherapy regimens. During the forecast period, the global CLL market will welcome five new drugs—Calquence (acalabrutinib), zanubrutinib, umbralisib, ublituximab, and Revlimid (lenalidomide). The...
-
Sector Analysis
Consumer and Market Insights: Spirits in South Africa
The South African Spirits market is led by the Whiskey category in both value and volume terms. The Whiskey category is also forecast to witness the fastest growth in both value and volume terms during 2015-2020. The consumers are opting for value for money products in the Spirits market. Distell Group Limited, Diageo Plc. and Pernod Ricard S.A. are the leading market players in the country.
-
Sector Analysis
Consumer and Market Insights: Spirits Market in South Africa
Of the eight categories analyzed, Whiskey will be the largest as well as fastest growing value category, registering a CAGR of 6.3% during 2015-2019 The Spirits market in South Africa accounted for nearly one-third of the overall Wine & Spirits retail sales during 2011-2014 Glass is the predominantly used packaging material in the market. The Spirits market in the country is highly competitive and is led by players such as Diageo plc and Distell Group Limited
-
Analyst Opinions
Australian Mortgage Market: Forecasts and Future Opportunities 2016
We estimate that growth in the value of balances outstanding for both owner-occupier and investment residential mortgages will be 6.1% in 2016, a slight decrease on the strong performance in 2015. The market will continue to decelerate over the forecast period as owner-occupier growth tapers off and investment property lending fails to make up for the slack.
-
Sector Analysis
United States Neuromodulation Devices Market Outlook to 2025
“What is covered in the report about the “United States Neuromodulation Devices Market”? GlobalData’s “United States Neuromodulation Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators...